Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete remission.
about
Unrelated donor transplantation for acute myelogenous leukemia in first remissionFactors predicting long-term survival after T-cell depleted reduced intensity allogeneic stem cell transplantation for acute myeloid leukemia.Early allo-SCT for AML with a complex aberrant karyotype--results from a prospective pilot study.Prognostic factors and outcomes of adult patients with acute myeloid leukemia after first relapse.Comparison of matched unrelated and matched related donor myeloablative hematopoietic cell transplantation for adults with acute myeloid leukemia in first remissionSelecting donor recipients.Long-term outcomes in patients with high-risk myeloid malignancies following matched related donor hematopoietic cell transplantation with myeloablative conditioning of BU, etoposide and CYOutcomes of allogeneic hematopoietic cell transplantation for adolescent and young adults compared with children and older adults with acute myeloid leukemia.Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid MalignanciesUnrelated donor transplants in adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission.Cytogenetic, molecular genetic, and clinical characteristics of acute myeloid leukemia with a complex karyotype.Strategies to reduce relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia.Full-intensity and reduced-intensity allogeneic stem cell transplantation in AML.Hematopoietic transplantation from adult unrelated donors as treatment for acute myeloid leukemia.Time-dependent effects of clinical predictors in unrelated hematopoietic stem cell transplantation.Blood and Marrow Transplant Clinical Trials Network: progress since the State of the Science Symposium 2007.Low relapse without excessive transplant-related mortality following myeloablative cord blood transplantation for acute leukemia in complete remission: a matched cohort analysis.Depletion of endogenous tumor-associated regulatory T cells improves the efficacy of adoptive cytotoxic T-cell immunotherapy in murine acute myeloid leukemia.Treatment of acute myeloid leukemia with hematopoietic stem cell transplantation.Allogeneic stem cell transplant in adult patients with acute myelogenous leukemia: a systematic analysis of international guidelines and recommendations.Hematopoietic stem cell transplantation for acute myeloid leukemia: to whom, when, and how.Allogeneic hematopoietic cell transplant for acute myeloid leukemia: Current state in 2013 and future directions.Frontline treatment of acute myeloid leukemia in adults.Outcome of allogeneic hematopoietic stem cell transplantation in adult patients with acute myeloid leukemia harboring trisomy 8.Improved outcome in relapsed and refractory myeloid malignancies for unrelated vs related donor allogeneic peripheral blood-derived hematopoietic cell transplantation.Successful outcome of allo-SCT in high-risk pediatric AML using chemotherapy-only conditioning and post transplant immunotherapy.Integration of cytogenetic and molecular alterations in risk stratification of 318 patients with de novo non-M3 acute myeloid leukemia.Duration of first remission and hematopoietic cell transplantation-specific comorbidity index but not age predict survival of patients with AML transplanted in CR2: a retrospective multicenter study.Acute myeloid leukemiaAcute Myeloid Leukemia
P2860
Q33841417-6B4BBA8E-1A90-465A-B736-D0A04B71B9F0Q33886217-48241B50-AFBB-4BE2-9F4D-D0902F6C5955Q34167404-36844B57-D8E4-4E53-899F-FC3D6546FB7BQ34255090-6AE8C920-35BF-4178-BAA5-F45F30675C3EQ34401926-E56C571A-AC84-4DDD-A84C-62C55623C652Q35170474-E683F9F4-CA0D-4A96-B750-520E5747DFD2Q35739130-5E8E91F9-F34D-407B-9FBF-37FDA355FC32Q35782852-9F87046C-0725-45EA-9A14-9213469A2B61Q36474066-F532DD04-801C-4DF2-90AA-24903E9C1ADEQ36742516-7791EF29-7664-4A70-88B2-4EFD95B8444BQ36808186-8615AF40-DD65-42A9-A031-9E3FD6534C14Q37000485-0E6D5B64-4674-42DC-8A23-74EB7CB8CB90Q37061964-E719E7A6-2786-4715-B0D3-C2E5E0DD0BF0Q37061969-2336C111-2311-4559-A5E0-A892A73152BFQ37079016-8D1A5952-22C4-4690-AF3C-FC0865400A8CQ37118840-87339146-561C-4B77-B93A-4F7C5A99B906Q37296965-827967EB-A650-4C97-A10C-B2B4F92AFBBBQ37412327-1605DEAD-3A5B-4773-A92D-1952F6D695F3Q37486793-8A8B06FA-ACD5-445E-88D8-CEA0C0C6AE8FQ37842488-34E47A12-BB22-494C-AD7E-F80D95B595B5Q38130168-07BC0743-5155-4CF7-9C43-87158580011BQ38207595-7E2AE93D-A7D0-401E-B4B8-99B5A9D62F0AQ38767583-4581B16C-F4A6-4025-BE89-8FD02D68B02CQ39036994-CBD2967D-F39A-4B8B-A745-314105416B2AQ46029759-26AE7F69-771C-4126-847F-266CB4E38949Q46535096-541C9042-F8DA-4AA5-A9F4-F9586C2D6545Q46606851-E589EBE8-CE45-4080-8F65-7B30B14638F2Q52880828-91D6E677-1424-41AF-BA6B-99498B7D1AD3Q58481761-F5528FF3-0FC7-4896-9682-7436E35E39B0Q58481811-D4D0407E-C0A5-4296-AC3F-53A0FF0F8CA5
P2860
Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete remission.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Impact of cytogenetics on outc ...... or second complete remission.
@ast
Impact of cytogenetics on outc ...... or second complete remission.
@en
type
label
Impact of cytogenetics on outc ...... or second complete remission.
@ast
Impact of cytogenetics on outc ...... or second complete remission.
@en
prefLabel
Impact of cytogenetics on outc ...... or second complete remission.
@ast
Impact of cytogenetics on outc ...... or second complete remission.
@en
P2093
P2860
P1433
P1476
Impact of cytogenetics on outc ...... or second complete remission.
@en
P2093
Armand Keating
Brent R Logan
Daniel J Weisdorf
Gordon W Dewald
Jacob M Rowe
Jayesh Mehta
Mark R Litzow
Meir Wetzler
Sharavi Gandham
Tanya Pedersen
P2860
P304
P356
10.1182/BLOOD-2006-10-043299
P407
P577
2007-03-20T00:00:00Z